A carregar...
A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
BACKGROUND: Based on the tax 327 phase iii trial, docetaxel-based chemotherapy is the standard first-line treatment for hormone-resistant prostate cancer (hrpc); however, there is some heterogeneity in the use of this agent in routine clinical practice. The aim of the present study was to examine th...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2854632/ https://ncbi.nlm.nih.gov/pubmed/20404974 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|